Published in Int J Reprod Med on January 26, 2017
International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod (2007) 6.08
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod (2011) 5.49
Birth after the reimplantation of a human embryo. Lancet (1978) 4.69
A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update (2006) 4.24
Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril (2013) 4.12
Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril (1995) 3.49
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril (2008) 2.59
Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet (2012) 2.39
Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation. Proc Natl Acad Sci U S A (2003) 2.27
Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod (2011) 2.10
A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization. Hum Reprod (2012) 2.05
Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod (2006) 1.87
Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertil Steril (2001) 1.76
Predictive factors in in vitro fertilization (IVF): a systematic review and meta-analysis. Hum Reprod Update (2010) 1.72
Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod (2002) 1.71
Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Hum Reprod (2011) 1.69
Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod (2007) 1.54
Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online (2006) 1.53
Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles. Fertil Steril (2012) 1.46
Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update (2013) 1.42
Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril (2003) 1.41
Dynamic changes in gene expression during human early embryo development: from fundamental aspects to clinical applications. Hum Reprod Update (2010) 1.28
Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod (2006) 1.26
The role of the endometrium and embryo in human implantation. Hum Reprod Update (2007) 1.24
Chromosome abnormalities in 1255 cleavage-stage human embryos. Reprod Biomed Online (2000) 1.16
Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril (1991) 1.14
Array CGH analysis shows that aneuploidy is not related to the number of embryos generated. Reprod Biomed Online (2012) 1.13
Technology requirements for preimplantation genetic diagnosis to improve assisted reproduction outcomes. Fertil Steril (2009) 1.11
Consequences of premature progesterone elevation on the outcome of in vitro fertilization: insights into a controversy. Fertil Steril (1997) 1.11
International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2006. Hum Reprod (2014) 1.10
Endometrial preparation: lessons from oocyte donation. Fertil Steril (1996) 1.08
Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer. Fertil Steril (2006) 1.06
Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet (2011) 1.05
Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids (2003) 1.05
Wide range of chromosome abnormalities in the embryos of young egg donors. Reprod Biomed Online (2006) 1.04
Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril (1994) 1.02
The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China. Hum Reprod (2013) 1.02
Current value of preimplantation genetic aneuploidy screening in IVF. Hum Reprod Update (2006) 1.01
Freeze-all policy: fresh vs. frozen-thawed embryo transfer. Fertil Steril (2015) 1.01
LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles. J Clin Endocrinol Metab (2012) 0.99
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer. Fertil Steril (2012) 0.97
Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism. Endocrinology (1993) 0.97
Oocyte number per live birth in IVF: were Steptoe and Edwards less wasteful? Hum Reprod (2005) 0.96
Test-tube babies, 1981. Nature (1981) 0.96
Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Reprod Biomed Online (2011) 0.95
Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer. Fertil Steril (1996) 0.95
The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments. Hum Reprod (2012) 0.94
Comparison of sperm retrieval and reproductive outcome in azoospermic men with testicular failure and obstructive azoospermia treated for infertility. Asian J Androl (2014) 0.94
Selection of good embryos for transfer depends on embryo cohort size: implications for the 'mild ovarian stimulation' debate. Hum Reprod (1999) 0.93
Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis. Reprod Biol Endocrinol (2010) 0.92
Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis. Fertil Steril (2014) 0.91
Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin. Reprod Biol Endocrinol (2014) 0.90
Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol: a matched case-control study. Gynecol Endocrinol (2011) 0.89
Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Hum Reprod (2015) 0.89
Array comparative genomic hybridization analyses of all blastomeres of a cohort of embryos from young IVF patients revealed significant contribution of mitotic errors to embryo mosaicism at the cleavage stage. Reprod Biol Endocrinol (2014) 0.89
Assisted reproductive technology in India: A 3 year retrospective data analysis. J Hum Reprod Sci (2013) 0.88
Impact of different patterns of sperm chromosomal abnormalities on the chromosomal constitution of preimplantation embryos. Fertil Steril (2009) 0.87
Accuracy and reproducibility of automated estradiol-17beta and progesterone assays using native serum samples: results obtained in the Belgian external assessment scheme. Hum Reprod (2007) 0.87
Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol (2014) 0.87
Human steroidogenesis: implications for controlled ovarian stimulation with exogenous gonadotropins. Reprod Biol Endocrinol (2014) 0.85
Progesterone-to-follicle index is better correlated with in vitro fertilization cycle outcome than blood progesterone level. Fertil Steril (2014) 0.85
Steroid levels in ovarian follicular fluid related to follicle size and health status during the normal menstrual cycle in women. Hum Reprod (1986) 0.84
High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study. Reprod Biol Endocrinol (2014) 0.84
Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech. Clinics (Sao Paulo) (2014) 0.83
A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology. Reprod Biol Endocrinol (2014) 0.81
Application of next-generation sequencing for 24-chromosome aneuploidy screening of human preimplantation embryos. Mol Cytogenet (2015) 0.80
Are circulating gonadotropin isoforms naturally occurring biased agonists? Basic and therapeutic implications. Rev Endocr Metab Disord (2011) 0.79
Lack of association between endogenous LH and pregnancy in GnRH antagonist protocols. Reprod Biomed Online (2011) 0.79
Elevated P level on the day of hCG administration is related to FSH dose: is it the whole truth? Hum Reprod (2010) 0.79
Twenty years' experience with the Swiss data registry for assisted reproductive medicine: outcomes, key trends and recommendations for improved practice. Swiss Med Wkly (2015) 0.78
Effect of preovulatory progesterone elevation and duration of progesterone elevation on the pregnancy rate of frozen-thawed embryo transfer in natural cycles. Fertil Steril (2014) 0.78
Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios. Transl Androl Urol (2016) 66.58
Cigarette Smoking and Semen Quality: A New Meta-analysis Examining the Effect of the 2010 World Health Organization Laboratory Methods for the Examination of Human Semen. Eur Urol (2016) 1.21
The missing piece in management of infertile couple-clinical andrology. Transl Androl Urol (2017) 0.75
The Society for Translational Medicine: clinical practice guidelines for sperm DNA fragmentation testing in male infertility. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation testing in patients with subclinical varicocele: is there any evidence? Transl Androl Urol (2017) 0.75
The importance of quality control and quality assurance in SDF testing. Transl Androl Urol (2017) 0.75
It is high time for clinical application of sperm DNA fragmentation testing. Transl Androl Urol (2017) 0.75
Risk factors associated with sperm DNA fragmentation. Transl Androl Urol (2017) 0.75
The debate on sperm DNA fragmentation test goes on. Transl Androl Urol (2017) 0.75
Restoration of fertility potential via targeted treatment approach. Transl Androl Urol (2017) 0.75
Future direction in sperm DNA fragmentation testing. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation in clinical practice. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation test results reflect the overall quality of the whole semen specimen. Transl Androl Urol (2017) 0.75
Development of treatment strategies in men with vulnerable sperm. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation for the evaluation of male infertility: clinical algorithms. Transl Androl Urol (2017) 0.75
Comparison of strategies to reduce sperm DNA fragmentation in couples undergoing ICSI. Transl Androl Urol (2017) 0.75
Current limitation and future perspective of sperm DNA fragmentation tests. Transl Androl Urol (2017) 0.75
Insights on the predictive accuracy of the sperm DNA fragmentation tests on male infertility. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation: laboratory and clinical aspects. Transl Androl Urol (2017) 0.75
Development of targeted therapeutic strategies and refinement of sperm DNA fragmentation testing. Transl Androl Urol (2017) 0.75
Use of sperm DNA fragmentation testing and testicular sperm for intracytoplasmic sperm injection. Transl Androl Urol (2017) 0.75
The price and value of sperm DNA fragmentation tests. Transl Androl Urol (2017) 0.75
Expanding our understanding of clinical laboratory testing in male infertility patients. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation: a key player in decision making. Transl Androl Urol (2017) 0.75
Understanding sperm DNA fragmentation. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation: overcoming standardization obstacles. Transl Androl Urol (2017) 0.75
The correct interpretation of sperm DNA fragmentation test. Transl Androl Urol (2017) 0.75
Integrating surgical and clinical andrology is essential to improve the quality of care delivered to infertile couples. Transl Androl Urol (2017) 0.75
Role of diagnostic intracytoplasmic sperm injection (ICSI) in the management of genetically determined zona pellucida-free oocytes during fertilization: a case report. Zygote (2020) 0.75
The complex nature of the sperm DNA damage process. Transl Androl Urol (2017) 0.75
One of the many missing links between infertility and sperm DNA fragmentation. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation testing reveals the overall quality of a semen sample. Transl Androl Urol (2017) 0.75
The role of female factors in the management of sperm DNA fragmentation. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation testing is the safe and economical way to go. Transl Androl Urol (2017) 0.75
Sperm DNA fragmentation: a rationale for its clinical utility. Transl Androl Urol (2017) 0.75
Unraveling the utility and limitations of clinical practice guidelines. Transl Androl Urol (2017) 0.75
The problem of mixing 'apples and oranges' in meta-analytic studies. Transl Androl Urol (2017) 0.75
Drawbacks of the current practice. Transl Androl Urol (2017) 0.75
Implication of sperm processing during assisted reproduction on sperm DNA integrity. Transl Androl Urol (2017) 0.75
From bench to clinic. Transl Androl Urol (2017) 0.75
Antioxidants for elevated sperm DNA fragmentation: a mini review. Transl Androl Urol (2017) 0.75
Is National Institute of Clinical Excellence (NICE) guideline a nice guideline? Transl Androl Urol (2017) 0.75
More good than harm should be expected when Testi-ICSI is applied to oligozoospermic men with post-testicular sperm DNA fragmentation. Transl Androl Urol (2017) 0.75